1. Value of MLH1 and MSH2 Mutations in the Appearance of Muir–Torre Syndrome Phenotype in HNPCC Patients Presenting Sebaceous Gland Tumors or Keratoacanthomas 
Giovanni Ponti, Lorena Losi, Monica Pedroni, Emanuela Lucci-Cordisco, Carmela Di Gregorio, Giovanni Pellacani, Stefania Seidenari 
Journal of Investigative Dermatology 
Volume 126, Issue 10, Pages (October 2006)
DOI: /sj.jid
Copyright © 2006 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
Genealogic three of suspected MTS linked to MSH2 mutations (del TT at 880 exo 5). A II-1 patient shows sebaceous carcinoma without visceral malignancy.
Journal of Investigative Dermatology  , DOI: ( /sj.jid )
Copyright © 2006 The Society for Investigative Dermatology, Inc Terms and Conditions

3. Figure 2
Immunohistochemical analysis of MMR proteins. (a) Lack of expression of MLH1 protein in sebaceous carcinoma. (b) Lack of expression of MSH2 protein in sebaceous carcinoma.
Journal of Investigative Dermatology  , DOI: ( /sj.jid )
Copyright © 2006 The Society for Investigative Dermatology, Inc Terms and Conditions

4. Figure 3
Clinical aspect of a keratoacanthoma in the MTS patient. Bar=10mm; lesion size: 24 × 18mm.
Journal of Investigative Dermatology  , DOI: ( /sj.jid )
Copyright © 2006 The Society for Investigative Dermatology, Inc Terms and Conditions